Investor Relations

We are a clinical-stage biopharmaceutical company focused on metabolic and endocrine disorders. We improve compliance, absorption, and more with our proprietary drug delivery technology.

NASDAQLPCN
YearTrailing 12-MonthsCalendar Year 2024Calendar Year 2023Calendar Year 2022Calendar Year 2021Calendar Year 2020Calendar Year 2019Calendar Year 2018Calendar Year 2017Calendar Year 2016Calendar Year 2015Calendar Year 2014Calendar Year 2013Calendar Year 2012Calendar Year 2011
ViewAll FilingsAnnual FilingsQuarterly FilingsCurrent FilingsRegistration StatementsSection 16Proxy & Information StatementsOther
FormDescriptionDateFormat
EFFECTNotice from the SEC of registration effectivenessNov 5, 2014Open Notice from the SEC of registration effectiveness in HTML.Open Notice from the SEC of registration effectiveness in DOC file.Open Notice from the SEC of registration effectiveness in PDF file.Open Notice from the SEC of registration effectiveness in XLS file.
EFFECTNotice from the SEC of registration effectivenessOct 15, 2014Open Notice from the SEC of registration effectiveness in HTML.Open Notice from the SEC of registration effectiveness in DOC file.Open Notice from the SEC of registration effectiveness in PDF file.Open Notice from the SEC of registration effectiveness in XLS file.
EFFECTNotice from the SEC of registration effectivenessApr 10, 2014Open Notice from the SEC of registration effectiveness in HTML.Open Notice from the SEC of registration effectiveness in DOC file.Open Notice from the SEC of registration effectiveness in PDF file.Open Notice from the SEC of registration effectiveness in XLS file.
CERTNASWhen a company wishes to "uplist" from pinksheets to NASDAQ it must first file S-1 and S-1a until final approval. Once final approval is obtained the SEC files a CERTNASMar 20, 2014Open When a company wishes to "uplist" from pinksheets to NASDAQ it must first file S-1 and S-1a until final approval. Once final approval is obtained the SEC files a CERTNAS in HTML.Open When a company wishes to "uplist" from pinksheets to NASDAQ it must first file S-1 and S-1a until final approval. Once final approval is obtained the SEC files a CERTNAS in DOC file.Open When a company wishes to "uplist" from pinksheets to NASDAQ it must first file S-1 and S-1a until final approval. Once final approval is obtained the SEC files a CERTNAS in PDF file.Open When a company wishes to "uplist" from pinksheets to NASDAQ it must first file S-1 and S-1a until final approval. Once final approval is obtained the SEC files a CERTNAS in XLS file.
SC 13GSchedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutionsFeb 14, 2014Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in HTML.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in DOC file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in PDF file.Open Schedule filed to report acquisition of beneficial ownership of 5% or more of a class of equity securities by passive investors and certain institutions in XLS file.
SC 13G/AAmendment to a previously filed SC 13GFeb 14, 2014Open Amendment to a previously filed SC 13G in HTML.Open Amendment to a previously filed SC 13G in DOC file.Open Amendment to a previously filed SC 13G in PDF file.Open Amendment to a previously filed SC 13G in XLS file.